Both in Pharmaceuticals
BioMarin Pharmaceuticals vs Protagonist Therapeutics
Over the past year BMRN returned +7.2% and PTGX returned +90.2%; their daily moves had a correlation of 0.26.
BMRN +7.2% PTGX +90.2%Growth of $1, one year, split-adjusted
| Metric | BMRN | PTGX |
|---|---|---|
| Price | $56.65 | $144.45 |
| Market cap | $10.97B | $9.35B |
| Today | +1.78% | +3.00% |
| 1 month | +0.8% | +4.2% |
| 6 months | +3.8% | +38.9% |
| Year to date | −4.7% | +65.4% |
| 1 year | +7.2% | +90.2% |
| Revenue growth (YoY) | +19.9% | +3749.2% |
| Gross margin | 79.5% | 100.0% |
| Net margin | 4.5% | 76.3% |
| P/E (TTM) | 150.3× | 112.7× |
| Price / sales | 3.2× | 33.1× |
| Net cash | -$3.31B | $782.6M |
| Dividend yield | — | — |
| Volatility (60d) | 26.9% | 32.2% |
| Short % of float | 6.2% | 16.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).